Cargando…

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma

BACKGROUND: Recent studies have shown that gamma interferon (IFN-γ) synergizes with the innate IFNs (IFN-α and IFN-β) to inhibit herpes simplex virus type 1 (HSV-1) replication in vitro. To determine whether this phenomenon is shared by other herpesviruses, we investigated the effects of IFNs on hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainz, Bruno, LaMarca, Heather L, Garry, Robert F, Morris, Cindy A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC554982/
https://www.ncbi.nlm.nih.gov/pubmed/15727684
http://dx.doi.org/10.1186/1743-422X-2-14
_version_ 1782122526065819648
author Sainz, Bruno
LaMarca, Heather L
Garry, Robert F
Morris, Cindy A
author_facet Sainz, Bruno
LaMarca, Heather L
Garry, Robert F
Morris, Cindy A
author_sort Sainz, Bruno
collection PubMed
description BACKGROUND: Recent studies have shown that gamma interferon (IFN-γ) synergizes with the innate IFNs (IFN-α and IFN-β) to inhibit herpes simplex virus type 1 (HSV-1) replication in vitro. To determine whether this phenomenon is shared by other herpesviruses, we investigated the effects of IFNs on human cytomegalovirus (HCMV) replication. RESULTS: We have found that as with HSV-1, IFN-γ synergizes with the innate IFNs (IFN-α/β) to potently inhibit HCMV replication in vitro. While pre-treatment of human foreskin fibroblasts (HFFs) with IFN-α, IFN-β or IFN-γ alone inhibited HCMV plaque formation by ~30 to 40-fold, treatment with IFN-α and IFN-γ or IFN-β and IFN-γ inhibited HCMV plaque formation by 163- and 662-fold, respectively. The generation of isobole plots verified that the observed inhibition of HCMV plaque formation and replication in HFFs by IFN-α/β and IFN-γ was a synergistic interaction. Additionally, real-time PCR analyses of the HCMV immediate early (IE) genes (IE1 and IE2) revealed that IE mRNA expression was profoundly decreased in cells stimulated with IFN-α/β and IFN-γ (~5-11-fold) as compared to vehicle-treated cells. Furthermore, decreased IE mRNA expression was accompanied by a decrease in IE protein expression, as demonstrated by western blotting and immunofluorescence. CONCLUSION: These findings suggest that IFN-α/β and IFN-γ synergistically inhibit HCMV replication through a mechanism that may involve the regulation of IE gene expression. We hypothesize that IFN-γ produced by activated cells of the adaptive immune response may potentially synergize with endogenous type I IFNs to inhibit HCMV dissemination in vivo.
format Text
id pubmed-554982
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5549822005-03-20 Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma Sainz, Bruno LaMarca, Heather L Garry, Robert F Morris, Cindy A Virol J Research BACKGROUND: Recent studies have shown that gamma interferon (IFN-γ) synergizes with the innate IFNs (IFN-α and IFN-β) to inhibit herpes simplex virus type 1 (HSV-1) replication in vitro. To determine whether this phenomenon is shared by other herpesviruses, we investigated the effects of IFNs on human cytomegalovirus (HCMV) replication. RESULTS: We have found that as with HSV-1, IFN-γ synergizes with the innate IFNs (IFN-α/β) to potently inhibit HCMV replication in vitro. While pre-treatment of human foreskin fibroblasts (HFFs) with IFN-α, IFN-β or IFN-γ alone inhibited HCMV plaque formation by ~30 to 40-fold, treatment with IFN-α and IFN-γ or IFN-β and IFN-γ inhibited HCMV plaque formation by 163- and 662-fold, respectively. The generation of isobole plots verified that the observed inhibition of HCMV plaque formation and replication in HFFs by IFN-α/β and IFN-γ was a synergistic interaction. Additionally, real-time PCR analyses of the HCMV immediate early (IE) genes (IE1 and IE2) revealed that IE mRNA expression was profoundly decreased in cells stimulated with IFN-α/β and IFN-γ (~5-11-fold) as compared to vehicle-treated cells. Furthermore, decreased IE mRNA expression was accompanied by a decrease in IE protein expression, as demonstrated by western blotting and immunofluorescence. CONCLUSION: These findings suggest that IFN-α/β and IFN-γ synergistically inhibit HCMV replication through a mechanism that may involve the regulation of IE gene expression. We hypothesize that IFN-γ produced by activated cells of the adaptive immune response may potentially synergize with endogenous type I IFNs to inhibit HCMV dissemination in vivo. BioMed Central 2005-02-23 /pmc/articles/PMC554982/ /pubmed/15727684 http://dx.doi.org/10.1186/1743-422X-2-14 Text en Copyright © 2005 Sainz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Sainz, Bruno
LaMarca, Heather L
Garry, Robert F
Morris, Cindy A
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
title Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
title_full Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
title_fullStr Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
title_full_unstemmed Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
title_short Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
title_sort synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC554982/
https://www.ncbi.nlm.nih.gov/pubmed/15727684
http://dx.doi.org/10.1186/1743-422X-2-14
work_keys_str_mv AT sainzbruno synergisticinhibitionofhumancytomegalovirusreplicationbyinterferonalphabetaandinterferongamma
AT lamarcaheatherl synergisticinhibitionofhumancytomegalovirusreplicationbyinterferonalphabetaandinterferongamma
AT garryrobertf synergisticinhibitionofhumancytomegalovirusreplicationbyinterferonalphabetaandinterferongamma
AT morriscindya synergisticinhibitionofhumancytomegalovirusreplicationbyinterferonalphabetaandinterferongamma